3-134603900-A-G
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_178554.6(KY):āc.1665T>Cā(p.Leu555Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.649 in 1,613,692 control chromosomes in the GnomAD database, including 343,051 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Genomes: š 0.63 ( 30750 hom., cov: 33)
Exomes š: 0.65 ( 312301 hom. )
Consequence
KY
NM_178554.6 synonymous
NM_178554.6 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.423
Genes affected
KY (HGNC:26576): (kyphoscoliosis peptidase) The protein encoded by this gene belongs to the transglutaminase-like superfamily. The protein is involved in the function, maturation and stabilization of the neuromuscular junction and may be required for normal muscle growth. Mutations in this gene are associated with myopathy, myofibrillar, 7. [provided by RefSeq, Apr 2017]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BP6
Variant 3-134603900-A-G is Benign according to our data. Variant chr3-134603900-A-G is described in ClinVar as [Benign]. Clinvar id is 1289017.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.423 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.849 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KY | NM_178554.6 | c.1665T>C | p.Leu555Leu | synonymous_variant | 11/11 | ENST00000423778.7 | NP_848649.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KY | ENST00000423778.7 | c.1665T>C | p.Leu555Leu | synonymous_variant | 11/11 | 5 | NM_178554.6 | ENSP00000397598.2 |
Frequencies
GnomAD3 genomes AF: 0.631 AC: 95865AN: 151962Hom.: 30734 Cov.: 33
GnomAD3 genomes
AF:
AC:
95865
AN:
151962
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.681 AC: 169566AN: 249096Hom.: 58872 AF XY: 0.671 AC XY: 90685AN XY: 135140
GnomAD3 exomes
AF:
AC:
169566
AN:
249096
Hom.:
AF XY:
AC XY:
90685
AN XY:
135140
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.651 AC: 951734AN: 1461610Hom.: 312301 Cov.: 62 AF XY: 0.649 AC XY: 471981AN XY: 727082
GnomAD4 exome
AF:
AC:
951734
AN:
1461610
Hom.:
Cov.:
62
AF XY:
AC XY:
471981
AN XY:
727082
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.631 AC: 95921AN: 152082Hom.: 30750 Cov.: 33 AF XY: 0.639 AC XY: 47491AN XY: 74346
GnomAD4 genome
AF:
AC:
95921
AN:
152082
Hom.:
Cov.:
33
AF XY:
AC XY:
47491
AN XY:
74346
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2507
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Mar 06, 2021 | - - |
Myofibrillar myopathy 7 Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Aug 19, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at